SK286071B6 - Farmaceutický prostriedok s obsahom undekanoátu testosterónu - Google Patents

Farmaceutický prostriedok s obsahom undekanoátu testosterónu Download PDF

Info

Publication number
SK286071B6
SK286071B6 SK1372-2001A SK13722001A SK286071B6 SK 286071 B6 SK286071 B6 SK 286071B6 SK 13722001 A SK13722001 A SK 13722001A SK 286071 B6 SK286071 B6 SK 286071B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
testosterone undecanoate
castor oil
liquid carrier
dissolved
Prior art date
Application number
SK1372-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK13722001A3 (sk
Inventor
De Henrik Nijs
Susan Chandler
Elizabeth Anne Perry
Josephine Joan Christine Ferdinando
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of SK13722001A3 publication Critical patent/SK13722001A3/sk
Publication of SK286071B6 publication Critical patent/SK286071B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Plant Substances (AREA)
SK1372-2001A 1999-04-01 2000-03-27 Farmaceutický prostriedok s obsahom undekanoátu testosterónu SK286071B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99302581 1999-04-01
PCT/EP2000/002677 WO2000059512A1 (en) 1999-04-01 2000-03-27 Formulation comprising testosteron undecanoate and castor oil

Publications (2)

Publication Number Publication Date
SK13722001A3 SK13722001A3 (sk) 2002-02-05
SK286071B6 true SK286071B6 (sk) 2008-02-05

Family

ID=8241306

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1372-2001A SK286071B6 (sk) 1999-04-01 2000-03-27 Farmaceutický prostriedok s obsahom undekanoátu testosterónu

Country Status (27)

Country Link
EP (1) EP1189620B1 (no)
JP (1) JP2002541111A (no)
KR (1) KR100666016B1 (no)
CN (1) CN1155385C (no)
AT (1) ATE269708T1 (no)
AU (1) AU768537B2 (no)
BR (1) BR0009465A (no)
CA (1) CA2366856C (no)
CZ (1) CZ298573B6 (no)
DE (1) DE60011771T2 (no)
DK (1) DK1189620T3 (no)
ES (1) ES2222199T3 (no)
HK (1) HK1043544A1 (no)
HU (1) HU229455B1 (no)
ID (1) ID30481A (no)
IL (2) IL145524A0 (no)
MX (1) MXPA01009919A (no)
NO (1) NO329420B1 (no)
NZ (1) NZ514290A (no)
PL (1) PL195163B1 (no)
PT (1) PT1189620E (no)
RU (1) RU2246296C2 (no)
SK (1) SK286071B6 (no)
TR (1) TR200102769T2 (no)
TW (1) TWI280124B (no)
WO (1) WO2000059512A1 (no)
ZA (1) ZA200107781B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907715D0 (en) * 1999-04-01 1999-05-26 Scherer Corp R P Pharmaceutical compositions
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
ATE319426T1 (de) 2003-11-11 2006-03-15 Mattern Udo Nasenformulierung mit kontrollierter freisetzung von sexualhormonen
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
EP2985026B1 (en) * 2005-04-15 2022-08-03 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
PT2068825E (pt) 2006-10-04 2011-02-11 M & P Patent Ag Sistema de administração de libertação controlada para aplicação nasal de neurotransmissores
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
US11304960B2 (en) * 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
ES2525520T3 (es) * 2010-04-12 2014-12-26 Clarus Therapeutics, Inc. Formulaciones orales de éster de testosterona y métodos para tratar la deficiencia de testosterona con las mismas
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
HUE037660T2 (hu) * 2011-01-26 2018-09-28 Allergan Inc Androgén készítmény szembetegség kezelésére
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
CA2950670A1 (en) 2014-06-17 2015-12-23 Merck Sharp & Dohme B.V. Stable formulations of testosterone undecanoate
WO2015193380A2 (en) * 2014-06-19 2015-12-23 Solural Pharma ApS Solid oral dosage form of lipophilic compounds
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20160193225A1 (en) * 2014-08-29 2016-07-07 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
SE9700642D0 (sv) * 1997-02-24 1997-02-24 Kronvall Stefan Med Ab Medel och sätt för förebyggande och behandling av det metabola syndromet

Also Published As

Publication number Publication date
TR200102769T2 (tr) 2002-05-21
NO20014718D0 (no) 2001-09-28
MXPA01009919A (es) 2002-04-24
NO20014718L (no) 2001-09-28
HU229455B1 (en) 2013-12-30
PL195163B1 (pl) 2007-08-31
CZ298573B6 (cs) 2007-11-14
KR20010108435A (ko) 2001-12-07
JP2002541111A (ja) 2002-12-03
ZA200107781B (en) 2002-12-20
BR0009465A (pt) 2002-01-08
DE60011771T2 (de) 2004-11-04
PT1189620E (pt) 2004-10-29
SK13722001A3 (sk) 2002-02-05
IL145524A0 (en) 2002-06-30
WO2000059512A1 (en) 2000-10-12
DE60011771D1 (de) 2004-07-29
EP1189620B1 (en) 2004-06-23
HUP0200453A3 (en) 2003-06-30
HK1043544A1 (en) 2002-09-20
EP1189620A1 (en) 2002-03-27
ID30481A (id) 2001-12-13
CZ20013507A3 (cs) 2002-03-13
TWI280124B (en) 2007-05-01
ES2222199T3 (es) 2005-02-01
HUP0200453A2 (hu) 2002-07-29
AU768537B2 (en) 2003-12-18
CN1155385C (zh) 2004-06-30
KR100666016B1 (ko) 2007-01-10
RU2246296C2 (ru) 2005-02-20
ATE269708T1 (de) 2004-07-15
IL145524A (en) 2006-12-31
CA2366856A1 (en) 2000-10-12
CN1346274A (zh) 2002-04-24
DK1189620T3 (da) 2004-08-16
PL351259A1 (en) 2003-04-07
CA2366856C (en) 2006-05-16
NZ514290A (en) 2003-08-29
AU4111100A (en) 2000-10-23
NO329420B1 (no) 2010-10-18

Similar Documents

Publication Publication Date Title
SK286071B6 (sk) Farmaceutický prostriedok s obsahom undekanoátu testosterónu
US11331325B2 (en) Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
JP5088804B2 (ja) 医療用組成物
JP2002541111A5 (no)
US20050287203A1 (en) Formulation comprising testosteron undecanoate and castor oil

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: MSD OSS B.V., OSS, NL

Free format text: FORMER OWNER: N.V. ORGANON, OSS, NL

Effective date: 20120326

PC4A Assignment and transfer of rights

Owner name: MERCK SHARP & DOHME B.V., BN HAARLEM, NL

Free format text: FORMER OWNER: ORGANON BIOSCIENCES NEDERLAND B.V., AB OSS, NL

Effective date: 20130729

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., AB OSS, NL

Free format text: FORMER OWNER: MSD OSS B.V., OSS, NL

Effective date: 20130729

MK4A Expiry of patent

Expiry date: 20200327